Literature DB >> 26232500

Specialized pro-resolving mediators: do they circulate in plasma?

Robert C Murphy1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26232500      PMCID： PMC4548769          DOI： 10.1194/jlr.C062356

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  9 in total

1.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.

Authors:  Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2014-03-16       Impact factor: 5.922

2.  Bioactive products formed in humans from fish oils.

Authors:  Carsten Skarke; Naji Alamuddin; John A Lawson; Xuanwen Li; Jane F Ferguson; Muredach P Reilly; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2015-07-15       Impact factor: 5.922

Review 3.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.

Authors:  Lee Hooper; Rachel L Thompson; Roger A Harrison; Carolyn D Summerbell; Andy R Ness; Helen J Moore; Helen V Worthington; Paul N Durrington; Julian P T Higgins; Nigel E Capps; Rudolph A Riemersma; Shah B J Ebrahim; George Davey Smith
Journal:  BMJ       Date:  2006-03-24

4.  Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.

Authors:  Anne Barden; Emilie Mas; Kevin D Croft; Michael Phillips; Trevor A Mori
Journal:  J Lipid Res       Date:  2014-09-03       Impact factor: 5.922

Review 5.  Resolution of acute inflammation in the lung.

Authors:  Bruce D Levy; Charles N Serhan
Journal:  Annu Rev Physiol       Date:  2013-12-02       Impact factor: 19.318

6.  Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA.

Authors:  Miao Liu; Ping Chen; Evelyne Véricel; Moreno Lelli; Laetitia Béguin; Michel Lagarde; Michel Guichardant
Journal:  J Lipid Res       Date:  2013-06-05       Impact factor: 5.922

7.  17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.

Authors:  Caroline Morin; Marco Sirois; Vincent Echavé; Roula Albadine; Eric Rousseau
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

8.  Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.

Authors:  Emilie Mas; Kevin D Croft; Paul Zahra; Anne Barden; Trevor A Mori
Journal:  Clin Chem       Date:  2012-08-21       Impact factor: 8.327

9.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

Authors:  B F McAdam; F Catella-Lawson; I A Mardini; S Kapoor; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205
  9 in total
  10 in total

1.  Resolvin E1 for reducing vascular calcification.

Authors:  Neil MacRitchie; Pasquale Maffia
Journal:  Cardiovasc Res       Date:  2019-08-01       Impact factor: 10.787

2.  EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids.

Authors:  Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2016-07-19       Impact factor: 5.922

3.  Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects.

Authors:  Randi K Johnson; Jonathan Manke; Monica Campbell; Michael Armstrong; Meher Preethi Boorgula; Gabriela Pinheiro; Cinthia Vila Nova Santana; Rasika A Mathias; Kathleen C Barnes; Alvaro Cruz; Nichole Reisdorph; Camila A Figueiredo
Journal:  J Allergy Clin Immunol       Date:  2022-03-15       Impact factor: 14.290

4.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

Review 5.  Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.

Authors:  Brian E Sansbury; Matthew Spite
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 6.  Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans.

Authors:  Chao-Wei Huang; Yi-Shan Chien; Yu-Jen Chen; Kolapo M Ajuwon; Harry M Mersmann; Shih-Torng Ding
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

Review 7.  Pro-Resolving Molecules-New Approaches to Treat Sepsis?

Authors:  Christa Buechler; Rebekka Pohl; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2017-02-23       Impact factor: 5.923

Review 8.  Omega-3 fatty acids in atherosclerosis and coronary artery disease.

Authors:  Magnus Bäck
Journal:  Future Sci OA       Date:  2017-10-05

9.  Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study.

Authors:  Ellen L Mozurkewich; Matthew Greenwood; Chelsea Clinton; Deborah Berman; Vivian Romero; Zora Djuric; Clifford Qualls; Karsten Gronert
Journal:  Front Pharmacol       Date:  2016-09-07       Impact factor: 5.810

10.  HPLC-MS/MS Oxylipin Analysis of Plasma from Amyotrophic Lateral Sclerosis Patients.

Authors:  Mauricio Mastrogiovanni; Andrés Trostchansky; Hugo Naya; Raúl Dominguez; Carla Marco; Mònica Povedano; Rubèn López-Vales; Homero Rubbo
Journal:  Biomedicines       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.